Opportunity Information: Apply for RFA HD 21 009
The Intellectual and Developmental Disabilities Research Centers (IDDRC) FY 2021 opportunity (RFA-HD-21-009) is a National Institutes of Health (NIH) discretionary grant announcement that supports the Eunice Kennedy Shriver IDDRC program using the P50 research center mechanism, with clinical trials allowed but not required ("Clinical Trial Optional"). The central aim is to strengthen and expand high-impact, multidisciplinary research centers focused on intellectual and developmental disabilities (IDD), with an emphasis on advancing diagnosis, prevention, treatment, and overall amelioration of IDD across the lifespan. Rather than funding only a single lab or a narrow project, the program is structured to build or sustain a coordinated center that can serve as an institutional hub for collaborative, interdisciplinary, and translational IDD science and for getting findings out to the broader community.
A key feature of the FOA is its two-part expectation for what an IDDRC must provide. First, the center must operate shared "Cores" that make research more efficient and more collaborative by providing specialized expertise, services, infrastructure, and resources that multiple investigators can use. These cores are intended to facilitate interdisciplinary and translational work in IDD and to support dissemination of research, meaning the center is expected to help move discoveries toward practical application and to communicate findings effectively. Importantly, the cores are designed to support not only projects funded under the P50 itself, but also a broader portfolio of IDD-related projects that are funded by other sources. The FOA makes clear that a large share of the research projects using these core facilities are expected to be supported through independent funding streams, including federal, state, and private organizations, which underscores that an IDDRC is meant to amplify and accelerate a wider ecosystem of funded research rather than function as an isolated grant.
Second, beyond maintaining cores, the center must include at least one specific research project that aligns with one of the FOA's identified focus themes representing areas of need in IDD research. While the announcement text provided here does not list those themes, the requirement signals that NIH expects each center application to anchor itself with a clearly defined scientific project that addresses a priority gap, demonstrating both the center's research direction and its ability to deliver concrete advances. In practice, that anchor project helps show how the cores will be used, what scientific questions the center will tackle, and how the center's structure will produce outcomes that matter for people with IDD, their families, clinicians, and service systems.
Eligibility is broad and spans many types of U.S.-based organizations. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, there are strict limits on foreign participation: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed. In short, the program is intended to fund U.S.-based centers without foreign components.
From a funding and administrative standpoint, the opportunity falls under CFDA 93.865 and uses the grant funding instrument type within the Health, Income Security and Social Services activity category. The original closing date listed is August 14, 2020, with a stated award ceiling of $800,000. The opportunity was created on April 2, 2020. While the provided record does not specify the number of expected awards, the structure and budget ceiling indicate NIH is aiming to fund robust center-level activities that include both shared infrastructure (cores) and focused scientific work (at least one research project), with the expectation that the center will also attract and support substantial externally funded IDD research that leverages the cores.
Overall, this FOA is best understood as a center-building and center-sustaining opportunity for institutions that already have, or can convincingly establish, a strong, multidisciplinary IDD research environment. Competitive applications would be expected to show an integrated plan for cores that genuinely enable cross-disciplinary collaboration and translation, a clearly compelling research project tied to a recognized IDD research need, and an institutional setting capable of supporting a broader community of investigators whose independently funded IDD projects will actively use and benefit from the IDDRC infrastructure.Apply for RFA HD 21 009
- The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865.
- This funding opportunity was created on 2020-04-02.
- Applicants must submit their applications by 2020-08-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $800,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): Intellectual and Developmental Disabilities Research Centers (IDDRC) FY 2021 (RFA-HD-21-009)
What is the IDDRC FY 2021 funding opportunity (RFA-HD-21-009)?
The Intellectual and Developmental Disabilities Research Centers (IDDRC) FY 2021 opportunity (RFA-HD-21-009) is a National Institutes of Health (NIH) discretionary grant announcement that supports the Eunice Kennedy Shriver IDDRC program using the P50 research center mechanism.
What is the main goal of this FOA?
The central aim is to strengthen and expand high-impact, multidisciplinary research centers focused on intellectual and developmental disabilities (IDD). The FOA emphasizes advancing diagnosis, prevention, treatment, and overall amelioration of IDD across the lifespan, and promoting collaborative, interdisciplinary, and translational IDD science with dissemination to the broader community.
Is this grant meant to fund a single research lab or a single narrow project?
No. The program is structured to build or sustain a coordinated center that functions as an institutional hub. It is designed to support collaborative and interdisciplinary work rather than funding only one lab or a narrowly defined standalone project.
What grant mechanism is used for this opportunity?
This opportunity uses the P50 research center mechanism.
Are clinical trials allowed under this FOA?
Yes. The FOA is listed as "Clinical Trial Optional," meaning clinical trials are allowed but not required.
What are the two major expectations for what an IDDRC must provide?
The FOA has a two-part expectation: (1) the center must operate shared "Cores" that provide specialized expertise, services, infrastructure, and resources to support multiple investigators; and (2) the center must include at least one specific research project aligned with one of the FOA's identified focus themes representing areas of need in IDD research.
What are "Cores" in the context of an IDDRC center grant?
Do the IDDRC cores only support projects funded by the P50 award?
No. The FOA specifies that the cores are intended to support not only projects funded under the P50 itself, but also a broader portfolio of IDD-related projects funded by other sources.
What kinds of external funding sources are expected to support projects that use the cores?
The FOA indicates that a large share of research projects using the core facilities are expected to be supported through independent funding streams, including federal, state, and private organizations.
What does the FOA mean by expecting the center to "amplify" a broader ecosystem of funded research?
Based on the description provided, the FOA positions an IDDRC as shared infrastructure that accelerates and supports a wider set of IDD research projects beyond the P50 itself. In other words, the center is expected to enable and strengthen many independently funded projects by providing commonly used core resources and expertise.
Is at least one research project required as part of the center?
Yes. Beyond maintaining cores, the center must include at least one specific research project that aligns with one of the FOA's identified focus themes representing areas of need in IDD research.
Are the FOA focus themes listed in the information provided here?
No. The description provided notes that the announcement text referenced here does not list the themes, but it clearly states that at least one project must align with one of the FOA's identified themes.
What role does the required research project play in a center application?
The required project serves as an anchor that helps demonstrate the center's scientific direction, how the cores will be used, what questions the center will tackle, and how the center structure will produce outcomes relevant to people with IDD, their families, clinicians, and service systems.
What kinds of outcomes does the FOA emphasize for IDD research?
The FOA emphasizes advances in diagnosis, prevention, treatment, and overall amelioration of intellectual and developmental disabilities across the lifespan, along with translation and dissemination of research findings to the broader community.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S.-based organizations, including: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses.
Are specific institution types explicitly called out as eligible?
Yes. The FOA explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.
Can foreign organizations apply?
No. Non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply.
Can a U.S. organization apply if it includes a non-U.S. component?
No. The FOA states that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under NIH policy for this opportunity?
No. The FOA states that foreign components as defined by NIH policy are not allowed.
What is the CFDA number for this opportunity?
The opportunity falls under CFDA 93.865.
What is the funding instrument type?
The funding instrument type is a grant.
What activity category is this opportunity associated with?
The opportunity is listed under the Health, Income Security and Social Services activity category.
What is the award ceiling for this FOA?
The stated award ceiling is $800,000.
What is the closing date listed for this opportunity?
The original closing date listed is August 14, 2020.
When was this opportunity created?
The opportunity was created on April 2, 2020.
Does the provided information specify how many awards NIH expects to make?
No. The provided record does not specify the number of expected awards.
What type of organization is this FOA best suited for?
Based on the description provided, this FOA is best understood as a center-building and center-sustaining opportunity for institutions that already have, or can convincingly establish, a strong, multidisciplinary IDD research environment.
What would a competitive application be expected to demonstrate?
Competitive applications would be expected to show an integrated plan for cores that enable cross-disciplinary collaboration and translation, a compelling research project tied to a recognized IDD research need, and an institutional setting capable of supporting a broader community of investigators whose independently funded IDD projects will use and benefit from the IDDRC infrastructure.
What does it mean that the center should support dissemination of research?
Based on the FOA description provided, the center is expected to help communicate findings effectively and support moving discoveries toward practical application, rather than keeping results confined within the research center.
Browse more opportunities from the same category: Health, Income Security and Social Services
Next opportunity: Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)
Previous opportunity: High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 21 009
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 21 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of Fertility Regulation Methods by Small Business (R43/R44 Clinical Trial Optional) Apply for RFA HD 21 007 Funding Number: RFA HD 21 007 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $225,000 |
| National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) Apply for PAR 20 169 Funding Number: PAR 20 169 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) Apply for RFA HD 21 006 Funding Number: RFA HD 21 006 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $499,999 |
| Collaborative Pediatric Critical Care Research Network (PL1 Clinical Trial Required) Apply for RFA HD 21 016 Funding Number: RFA HD 21 016 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project(U24) (Clinical Trial Not Allowed) Apply for RFA HG 20 039 Funding Number: RFA HG 20 039 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project (U24 Clinical Trial Not Allowed) Apply for RFA HD 21 008 Funding Number: RFA HD 21 008 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| NICHD Research Education Programs (R25 Clinical Trial Not Allowed) Apply for PAR 20 250 Funding Number: PAR 20 250 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $150,000 |
| Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) Apply for RFA HD 21 020 Funding Number: RFA HD 21 020 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) Apply for PAR 20 130 Funding Number: PAR 20 130 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Limited Competition: Data Coordinating Center (DCC) for Completion of Ongoing MFMU Network Protocols (U24 Clinical Trial Optional) Apply for RFA HD 21 028 Funding Number: RFA HD 21 028 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Limited Competition: Clinical Centers for Completion of Ongoing MFMU Network Protocols (UG1 Clinical Trial Optional) Apply for RFA HD 21 029 Funding Number: RFA HD 21 029 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) Apply for PAR 20 298 Funding Number: PAR 20 298 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $300,000 |
| Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) Apply for PAR 20 300 Funding Number: PAR 20 300 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) Apply for PAR 20 299 Funding Number: PAR 20 299 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed) Apply for RFA HD 21 030 Funding Number: RFA HD 21 030 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) Apply for RFA HD 22 003 Funding Number: RFA HD 22 003 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Data Coordinating Center for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (U24 Clinical Trial Required) Apply for RFA HD 21 032 Funding Number: RFA HD 21 032 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial - Clinical Sites (UG1 Clinical Trial Required) Apply for RFA HD 21 031 Funding Number: RFA HD 21 031 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $150,000 |
| Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) Apply for PAR 21 115 Funding Number: PAR 21 115 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) Apply for RFA NS 21 015 Funding Number: RFA NS 21 015 Agency: National Institutes of Health Category: Health, Income Security and Social Services Funding Amount: $15,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 21 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
